Innate Pharma SA 20-F for FY2023
Innate Pharma SA (IPHA)
20-F
2024-04-04
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 20-F
Innate Pharma SA filed this 20-F on April 4, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 61.64M EUR
- up 6.9% from 57.67M EUR a year earlier
- Net loss
- 7.57M EUR
- compared with a net loss of 58.1M EUR a year earlier
- Diluted EPS
- -0.09 EUR
- compared with -0.73 EUR a year earlier